Sex Differences in the Expression of Hepatic Drug Metabolizing Enzymes
David J. Waxman(Boston University), Minita G. Holloway(Boston University)
Cited by 821
Related Papers
STAT5b Down-regulates Peroxisome Proliferator-activated Receptor α Transcription by Inhibition of Ligand-independent Activation Function Region-1trans-Activation Domain
|Journal of Biological Chemistry|1999|78
Role of the Cytokine-induced SH2 Domain-containing Protein CIS in Growth Hormone Receptor Internalization
|Journal of Biological Chemistry|2005|67
Inhibitory Cross-talk between STAT5b and Liver Nuclear Factor HNF3β
|Journal of Biological Chemistry|2001|65
Metronomic cyclophosphamide activation of anti-tumor immunity: tumor model, mouse host, and drug schedule dependence of gene responses and their upstream regulators
|BMC Cancer|2016|40
Role of Hepatocyte Nuclear Factors in Transcriptional Regulation of Male-specific CYP2A2
|Journal of Biological Chemistry|2004|32